Barron\'s - 21.10.2019

(Barry) #1

October 21, 2019 BARRON’S 9


Faking Brexit


NOW IS THE CRUCIAL MOMENT. A BREXIT DEAL IS AT


hand. If it passes, and is put into force before the


deadline of Halloween in America, there is a chance


thatbyThanksgiving,conversationsonthematterwill


have petered out to a few hopeful comments about


whatitmeansforgrossdomesticproduct.Ifso,those


ofuswhohaven’ttakenthesix-monthsabbaticalfrom


workandfamilythatseemsneededtofigureoutwhattheheckisgoing


on over there could yet pass unnoticed.


Dangerlurks,however.Thesenextfewdayswillbring


more Brexit talk than usual: clients, Facebook friends,


Gary from sales, who can’t believe you haven’t seen Life


ofBrian .Here’salast-minuteguideforAmericaninves-


tors pretending to understand Brexit.


Brexitisaportmanteau,ormushingtogetherofwords,


likebromance,turducken,andChunnel.ItmeansBritish


exit, in this case from the European Union, a trade bloc


whosemembersareunitedineverythingexceptlanguage,


culture,politics,wealth,fiscalviability,historicharmony,contiguousge-


ography, and in some cases, currency.


Evenunderamiddle-groundoutcome,BrexitcouldcosttheBritish


economy6.5%ofGDP,UBSreckons.Butthat’scumulativelyoverseven


years,takenasapercentageofoneyear’sGDP.Andmorethanhalfof


ithasalreadybeenendured,startingin2016,whenBrexitwasbornas


a you-wouldn’t-dare referendum, and voters dared.


Muchofthediscussionhasseemedlikeanegg-centereddebate:soft


orhard,butitwon’tbeovereasy.AsoftBrexitmeansstayingclosely


aligned with the EU on trade, and is favored by Britons who oppose


leaving.Hardmeansacleanbreak,andthatcouldcostanestimated9%


of GDP cumulatively, along with 450,000 jobs.


Protip:IfaBrexitdiscussiongetstoodetailed,scaretheotherparty


offbyinsistingthatahardexitwould“forcetheBOEbacktotheZLB


withmoreQE.”Justincaseyourbluffiscalled,that’sBankofEngland,


zerolowerbound,andquantitativeeasing,anditmeansifyouBrexit-


’til-you-wrexit,spenderswillneedtobestimulated,andsavers,scolded.


Don’tgetboggeddownwiththeplayers.Theyturnovertooquickly


tolearntheirnames.There’saguynamedBorisJohnson,whopeople


comparetoDonaldTrump,becausehe’sbrashandhasamopofblond


hair.“We’vegotagreatnewdeal,” hetweetedthispastweek,whichis


classic Trump, but then, sometimes he jogs in shorts, which is not.


Anyhow,thenewdealtriestosolvetheissueofthe“Irishbackstop,”


whichhasnothingtodowithoffshoretaxloopholes,orleavingparties


withoutsayinggoodbye,andeverythingtodowithavoidingnewchecks


or infrastructure between Ireland, which is in the EU, and Northern


Ireland,whichispartoftheU.K.ThispartofBrexitisthemostsensi-


tive, and acceptance of the new deal is not assured.


Stockstendtopriceinworst-casescenarios,andanythingotherthan


ahardBrexitcouldleadtoupsideforattractivelypricedU.K.names.


UBS highlights home builders Berkeley Group Holdings (ticker:


BKG.UK) and Taylor Wimpey (TW.UK), retailer Tesco (TSCO.UK),


and Lloyds Banking Group (LYG).


IfyouenduptrappedinaBrexitconversationandcan’tremember


thosecompanies,Britishnamesareeasytoinventbycombiningsylla-


blesthatsoundvaguelyprofane,butaren’t.Justtellpeopleyoubought


someBottomsworth&Wiggles,andarethinkingaboutwritingtheputs


on A.J. Fufferton. Both look oversold.


A portfolio manager popped bythispastweekandtalked


about three stocks he likes on three continents. Damon


Ficklin comes from Polen Capital in Boca Raton, Fla.,


which oversees $30 billion across separate accounts and


mutual funds. He used to work on Polen Growth fund


(POLRX)andhasmovedtoPolenGlobalGrowth(PGIRX),


whichistiny,buthasreturned18%ayearoverthreeyears,


rankingamongthetop2%ofpeers,accordingtoMorning-


star.


Ficklinisbullishon CSL (CSL.Australia),basedinAustralia; Essi-


lorLuxottica (EL.France)inFrance;and Zoetis (ZTS),inNewJersey.


Ifthereisathemehere,it’sprosperous,pricey,andpeppy.Allthreego


forover30timesthisyear’sestimatedearnings,andhaveagoodshot


at growing earnings at a double-digit pace for years to come.


CSLspecializesinIVIGorintravenousimmunoglobulintreatments.


Thoseinvolveobtainingantibodiesfromthebloodofhealthypeopleand


deliveringthemtopeoplewhoseantibodiesarecompromisedbydisease,


orbychemotherapy.Thecompanyalsohasahandinfluvaccines.Reve-


nues have grown at a compounded 9% a year over the past decade.


Luxottica of Italy was once the subject of a 60 Minutes piece on


whether it controls too much of the market for eyeglass frames. That


was before last year’s merger with French lens giant Essilor, to form


EssilorLuxottica. Europe, it seems, has figured out a new way to tax


Facebook and Google—by charging more for our ability to see our


screens. Ficklin says once these companies integrate their supply


chains, earnings growth could find a higher gear. I bet.


Zoetismakesmedicineforcompanionanimalsandlivestock,andhas


exposuretorisingwealthintwoways:morespendingonpetsandin-


creasedconsumptionofprotein.Animaldrugstendnottofaceasmuch


generic competition as human ones, even after patents expire. Zoetis


isbranchingoutintotreatmentsfornewailments,likeanimalpsoriasis.


Iftheyaregoingtostarttreatinghumanstuffinpets,thepossibilities


seemendless.Thereisanxiety,attentiondeficit,andtheoneinthecom-


mercialswheretheguyholdsupcrookedvegetables,butheisn’ttalking


about cooking.


email: [email protected]


Stockstendtopricein


worst-casescenarios.


Adealcouldleadto


upsideforattractively


pricedU.K.names.


Streetwise


By Jack Hough

Free download pdf